ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS
(Before
April 2001)
from April 2001:
Maintenance
interferon for chronic hepatitis C: More issues than answers?
Written
by Gregory T. Everson, M.D.
(with full PDF
of this article)
(4/30/2001)
Index
of 5 Blood Tests Used to Predict Liver Fibrosis Instead of Biopsy
Article written by French Hepatitis research
group
(4/30/2001)
Avascular Necrosis in HIV: case studies
With full report of this study in PDF
format
(4/12/2001)
Virologic
Response To Pegasys With Genotype 4 in Small Study Group
(4/10/2001)
Excerpts from
Press Announcement Of Application to the FDA for 1 Efavirenz Pill Per
Day Instead of 3 200 mg Pills
(4/10/2001)
Study
Finds Increasing HIV Incidence Among Women: almost 300% from 1986 to 1999
(4/5/2001)
It's
Time to Research TDM
The Time
Has Come To Accelerate Research Into Using TDM To Adjust Low Drug Blood
Levels For the Purpose Of Improving Viral Load Response to HAART
(4/5/2001)
Merck
Experimental Therapeutic HIV Vaccine
Articles from Reuters & the Wall St.
Journal
(4/3/2001)
Highlights
from
The 36th Annual Meeting of EASL
(European Association for the Study of the Liver) April 18-22, 2001, Prague,
Czech Republic
Written
for NATAP by Harvey S. Bartnof, MD
(4/21/2001)
Report
for NATAP from the
4th
International Conference on Nutrition and HIV Infection
Second European Workshop
on Lipodystrophy
Written for NATAP by Graeme Moyle,
MD, MBBS
(4/27/2001)
Reports
for NATAP from the
2nd International Workshop
on Clinical Pharmacology of HIV Therapy
April
2-4, 2001 Noordwijk, the Netherlands
(4/10/2001)
Maintenance
interferon for chronic hepatitis C: More issues than answers?
Written
by Gregory T. Everson, M.D.
(with full PDF
of this article)
(4/30/2001)
Index
of 5 Blood Tests Used to Predict Liver Fibrosis Instead of Biopsy
Article written by French Hepatitis research
group
(4/30/2001)
Avascular Necrosis in HIV: case studiesWith full report of this study in PDF format
(4/12/2001)
Virologic
Response To Pegasys With Genotype 4 in Small Study Group
(4/10/2001)
Excerpts from
Press
Announcement Of Application to the FDA for 1 Efavirenz Pill Per Day Instead
of 3 200 mg Pills
(4/10/2001)
Study
Finds Increasing HIV Incidence Among Women: almost 300% from 1986 to 1999
(4/5/2001)
It's
Time to Research TDM
The Time
Has Come To Accelerate Research Into Using TDM To Adjust Low Drug Blood
Levels For the Purpose Of Improving Viral Load Response to HAART
(4/5/2001)
Merck
Experimental Therapeutic HIV Vaccine
Articles from Reuters & the Wall St.
Journal
(4/3/2001)